Yuanshen Mao

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Endoplasmic Reticulum Stress

Transforming Growth Factor

Prostate Cancer

Top Venues

BioMed research international

Pharmaceutical biology

This page only lists publications with an associated author ORCID identifier.

Publications

Wenfeng Li, Yuanshen Mao, Bao Hua, Xin Gu, Chao Lu, Bin Xu, Weixin Pan
Sasanquasaponin inhibited epithelial to mesenchymal transition in prostate cancer by regulating the PI3K/Akt/mTOR and Smad pathways. Pharmaceutical biology 60 (1) (2022)
Yuanshen Mao, Wenfeng Li, Bao Hua, Xin Gu, Weixin Pan, Qi Chen, Bin Xu, Zhong Wang, Chao Lu
Silencing of ELK3 Induces S-M Phase Arrest and Apoptosis and Upregulates SERPINE1 Expression Reducing Migration in Prostate Cancer Cells. BioMed research international 2020 (2020)
Xiaobin Jiang, Ping Jiang, Yuanshen Mao
Performance of Modified Early Warning Score (MEWS) and Circulation, Respiration, Abdomen, Motor, and Speech (CRAMS) score in trauma severity and in-hospital mortality prediction in multiple trauma patients: a comparison study. PeerJ 7 (2019)